Rate My Professor Alexander Tups

Tups' research centers on neuroendocrine regulation of metabolism, particularly interactions between adiposity signals leptin and insulin in the hypothalamus to sustain energy homeostasis, identification of novel glucose metabolism pathways, and neuroendocrinology of nutrition-related diseases like the link between type 2 diabetes and Alzheimer's disease. His lab explores gene therapy and nutritional interventions for obesity and metabolic disorders. Funding supports his work from Return on Science (Otago Innovation), Maurice Wilkins Centre, Royal Society of New Zealand Marsden Fund, and German Research Foundation. Key publications include "A dahlia flower extract has antidiabetic properties by improving brain insulin action" (Pretz et al., Life Metabolism, 2023), "Obesity pharmacotherapy: incretin action in the central nervous system" (Boer et al., Trends in Pharmacological Sciences, 2022), "Leptin regulates glucose homeostasis via the canonical Wnt pathway in zebrafish" (Kamstra et al., FASEB Journal, 2022), and "A New Zealand green-lipped mussel oil-enriched high-fat diet improves body weight and glucose homeostasis in mice" (Loehfelm et al., British Journal of Nutrition, 2021). Tups has published over 40 research papers and received the Michael Harbuz Prize for neuroendocrine research (2009, UK) and Ernst and Berta Sharrer Award (2014, Germany). His contributions include developing Dahlia4, a patented natural glucose support product from neuroscience and metabolism research.